Before Peter Thiel invested, research on herpes vaccine began in US hotel rooms

(credit: ZaldyImg)

The researcher who conducted a controversial 2016 herpes vaccine trial on the island of St. Kitts without federal safety oversight had secretly begun the trial in the US three years earlier. He began them in hotel rooms not far from his academic lab. That’s according to a new investigation by Kaiser Health News.

That researcher, the late Dr. William Halford of Southern Illinois University, administered shots to at least eight people with herpes in 2013. Without any federal or institutional approval or oversight, he administered the shots himself in rooms at a Holiday Inn Express and a Crowne Plaza Hotel within a short drive from SIU. Halford, who passed away from cancer in June of this year, was a microbiologist, not a physician.

Several people who received the vaccine have since complained to the FDA and SIU. They reported potential side effects of the vaccine including large, painful rashes and becoming infected with a strain of herpes different from their initial infection.

Read 10 remaining paragraphs | Comments

Ars Technica

Post Author: martin

Martin is an enthusiastic programmer, a webdeveloper and a young entrepreneur. He is intereted into computers for a long time. In the age of 10 he has programmed his first website and since then he has been working on web technologies until now. He is the Founder and Editor-in-Chief of BriefNews.eu and PCHealthBoost.info Online Magazines. His colleagues appreciate him as a passionate workhorse, a fan of new technologies, an eternal optimist and a dreamer, but especially the soul of the team for whom he can do anything in the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.